Zentalis Pharmaceuticals, Inc.
$336.07M- Market cap
- $287.40M
- Debt
- +$82.57M
- Cash
- −$33.90M
Capital structure 78% equity / 22% debt · EV / Revenue 4.98x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ZNTL · current priceP/S 4.26x
$4.01Latest market snapshot
Implied fair value · at PDD's multiple
$1.7855.5% below market
0.94 ZNTL revenue / share×1.90x PDD P/S=$1.78
Market $4.01Implied $1.78
PDD · current priceP/S 1.90x
$82.23Latest market snapshot
Implied fair value · at ZNTL's multiple
$188.32129.0% above market
44.18 PDD revenue / share×4.26x ZNTL P/S=$188.32
Market $82.23Implied $188.32